サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1559468

前庭検査システムの世界市場：洞察、競合情勢、市場予測：2030年

Vestibular Testing Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
前庭検査システムの世界市場：洞察、競合情勢、市場予測：2030年
出版日: 2024年09月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

前庭検査システムの市場規模は、2024年から2030年までの予測期間中に6.31%のCAGRで拡大すると予測されています。めまい、立ちくらみ、平衡感覚の問題などの前庭障害の有病率の上昇、前庭障害に関連する不安や心理的要因を経験する患者の増加などが、包括的な診断ソリューションの需要を促進すると予測されます。バランス関連障害に罹患しやすい世界人口の高齢化も、高齢者がこれらの症状に苦しみ、医療介入を求める可能性が高いことから、市場の拡大に寄与しています。このように、これらすべての要因が、2024年から2030年までの予測期間中、前庭検査システム市場の成長を促進する重要な要因となっています。

米国国立衛生研究所（2023年）によると、良性発作性頭位めまい症（BPPV）は、前庭系の自己制限性末梢性めまいの最も一般的なタイプです。また、BPPVは、2022年にめまいの症状を呈する患者の17%から42%という大きな割合を占めています。さらに、Hearing Health Foundation（2024）によると、メニエール病の世界の発症率の推定値はかなりばらつきがあり、年間10万人あたり3.5～513例です。

世界保健機関（WHO）のデータ（2023年）によると、世界全体で180万人が多発性硬化症（MS）に罹患しているとされています。多発性硬化症は、認知、感情、運動、感覚、または視覚領域の機能に影響を及ぼし、人の免疫システムが脳や脊髄を攻撃した結果として発症します。MSは前庭障害につながる可能性があるため、免疫系による脳や脊髄への攻撃は、平衡感覚や空間定位に関わる神経を損傷する可能性があります。そのため、MSによる神経障害は前庭系に直接影響を与え、市場の成長を後押しします。

世界保健機関（WHO）は（2021年）、2015年から2050年の間に、60歳以上で倒れる人は12%から22%に倍増し、最終的に2050年には世界全体で21億人に達すると述べています。さらに、2030年には6人に1人が60歳以上になるといいます。このような人口動態の変化は、前庭障害の有病率の増加と密接に関連しています。高齢化社会では、前庭系の生理的変性や、平衡感覚や空間識の他の老化性変化により、前庭障害に罹患しやすくなるからです。

したがって、上記のすべての要因が、2024年から2030年までの予測期間中、前庭検査システム市場を牽引すると予想されます。

当レポートでは、世界の前庭検査システム市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 前庭検査システム市場レポートのイントロダクション

第2章 前庭検査システム市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 前庭検査システム市場の主な要因分析

  • 前庭検査システムの市場促進要因
  • 前庭検査システムの市場抑制要因と課題
  • 前庭検査システムの市場機会

第6章 前庭検査システム市場におけるポーターのファイブフォース分析

第7章 前庭検査システム市場評価

  • 製品別
    • ビデオ眼振検査（VNG）
    • 前庭誘発筋電位（VEMP）
    • 自覚的視性垂直位（SVV）
    • ロータリーチェア検査
  • 用途別
    • 前庭障害の診断
    • 前庭リハビリテーション
  • エンドユーザー別
    • 病院と診療所
    • 外来手術センター
    • 聴覚センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 前庭検査システム市場の企業と製品プロファイル

  • Interacoustics A/S
  • Natus Medical Incorporated
  • SECURE HEALTH, INC.
  • Visteon Corporation
  • BioMed Jena GmbH
  • Esumedics GmbH
  • INVENTIS S.r.l.
  • MedRx
  • Grason-Stadler (GSI)
  • Happersberger otopront GmbH
  • Micro Medical Devices (MMD), Inc.
  • Homoth Medizinelektronik GmbH & Co. KG
  • BeOn Solutions srl
  • Evolution Optiks Limited

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vestibular Testing System Market in Global (2021-2030)
  • Table 3: Vestibular Testing System Market in Global by Product (2021-2030)
  • Table 4: Vestibular Testing System Market in Global by Application (2021-2030)
  • Table 5: Vestibular Testing System Market in Global by End-User (2021-2030)
  • Table 6: Vestibular Testing System Market in Global by Geography (2021-2030)
  • Table 7: Vestibular Testing System Market in North America (2021-2030)
  • Table 8: Vestibular Testing System Market in the United States (2021-2030)
  • Table 9: Vestibular Testing System Market in Canada (2021-2030)
  • Table 10: Vestibular Testing System Market in Mexico (2021-2030)
  • Table 11: Vestibular Testing System Market in Europe (2021-2030)
  • Table 12: Vestibular Testing System Market in France (2021-2030)
  • Table 13: Vestibular Testing System Market in Germany (2021-2030)
  • Table 14: Vestibular Testing System Market in United Kingdom (2021-2030)
  • Table 15: Vestibular Testing System Market in Italy (2021-2030)
  • Table 16: Vestibular Testing System Market in Spain (2021-2030)
  • Table 17: Vestibular Testing System Market in the Rest of Europe (2021-2030)
  • Table 18: Vestibular Testing System Market in Asia-Pacific (2021-2030)
  • Table 19: Vestibular Testing System Market in China (2021-2030)
  • Table 20: Vestibular Testing System Market in Japan (2021-2030)
  • Table 21: Vestibular Testing System Market in India (2021-2030)
  • Table 22: Vestibular Testing System Market in Australia (2021-2030)
  • Table 23: Vestibular Testing System Market in South Korea (2021-2030)
  • Table 24: Vestibular Testing System Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Vestibular Testing System Market in the Rest of the World (2021-2030)
  • Table 26: Vestibular Testing System Market in the Middle East (2021-2030)
  • Table 27: Vestibular Testing System Market in Africa (2021-2030)
  • Table 28: Vestibular Testing System Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vestibular Testing System Market in Global (2021-2030)
  • Figure 3: Vestibular Testing System Market in Global by Product (2021-2030)
  • Figure 4: Vestibular Testing System Market in Global by Application (2021-2030)
  • Figure 5: Vestibular Testing System Market in Global by End-User (2021-2030)
  • Figure 6: Vestibular Testing System Market in Global by Geography (2021-2030)
  • Figure 7: Vestibular Testing System Market in North America (2021-2030)
  • Figure 8: Vestibular Testing System Market in the United States (2021-2030)
  • Figure 9: Vestibular Testing System Market in Canada (2021-2030)
  • Figure 10: Vestibular Testing System Market in Mexico (2021-2030)
  • Figure 11: Vestibular Testing System Market in Europe (2021-2030)
  • Figure 12: Vestibular Testing System Market in France (2021-2030)
  • Figure 13: Vestibular Testing System Market in Germany (2021-2030)
  • Figure 14: Vestibular Testing System Market in United Kingdom (2021-2030)
  • Figure 15: Vestibular Testing System Market in Italy (2021-2030)
  • Figure 16: Vestibular Testing System Market in Spain (2021-2030)
  • Figure 17: Vestibular Testing System Market in the Rest of Europe (2021-2030)
  • Figure 18: Vestibular Testing System Market in Asia-Pacific (2021-2030)
  • Figure 19: Vestibular Testing System Market in China (2021-2030)
  • Figure 20: Vestibular Testing System Market in Japan (2021-2030)
  • Figure 21: Vestibular Testing System Market in India (2021-2030)
  • Figure 22: Vestibular Testing System Market in Australia (2021-2030)
  • Figure 23: Vestibular Testing System Market in South Korea (2021-2030)
  • Figure 24: Vestibular Testing System Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Vestibular Testing System Market in the Rest of the World (2021-2030)
  • Figure 26: Vestibular Testing System Market in the Middle East (2021-2030)
  • Figure 27: Vestibular Testing System Market in Africa (2021-2030)
  • Figure 28: Vestibular Testing System Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0753

Vestibular Testing System Market By Product (Videonystagmography (VNG), Vestibular Evoked Myogenic Potentials (VEMP), Subjective Visual Vertical (SVV), And Rotary Chair Testing), Application (Diagnosis Of Vestibular Disorders And Vestibular Rehabilitation), End-User (Hospital And Clinics, Ambulatory Surgical Centers, Audiology Centres, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of vestibular disorders, neurological disorders, among others globally

The vestibular testing system market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030. The rising prevalence of vestibular disorders, such as vertigo, dizziness, and balance issues, increasing number of patients experiencing anxiety and psychological factors associated with vestibular disorders, among others are expected to drive the demand for comprehensive diagnostic solutions. The aging global population, which is more susceptible to balance-related disorders, also contributes to the growing market, as older adults are more likely to suffer from these conditions and seek medical intervention. Thus, all these factors serve as key factors driving the growth of the vestibular testing system market during the forecast period from 2024 to 2030.

Vestibular Testing System Market Dynamics:

According to the National Institute of Health (2023), benign paroxysmal positional vertigo (BPPV) represents the vestibular system's most prevalent type of self-limiting peripheral vertigo. This also indicated that BPPV accounts for a significant proportion, ranging from 17% to 42%, of patients presented with vertigo symptoms globally in the year 2022. Moreover, according to Hearing Health Foundation (2024), estimates of the global incidence of Meniere's disease exhibit considerable variability, ranging from 3.5 to 513 cases per 100,000 individuals annually.

According to the National Institute of Health (2023), the pooled prevalence of vestibular disorders among children and adolescents was 30.4%. This included participants aged 1 to 19 years from 15 different countries, highlighting the widespread occurrence of these disorders in young populations globally.

These findings highlight the rising number of vestibular disorders among the global population, thus driving the demand for vestibular testing systems. As healthcare providers seek to diagnose and manage these disorders accurately, the need for efficient and precise diagnostic tools increases, thereby boosting the market for vestibular testing systems.

As per data by the World Health Organization (2023), it was stated that 1.8 million people had multiple sclerosis (MS) globally. It affects function in cognitive, emotional, motor, sensory, or visual areas and occurs as a result of a person's immune system attacking their brain and spinal cord. Since MS can lead to vestibular disorders, the immune system's attack on the brain and spinal cord can damage the nerves involved in balance and spatial orientation. Thus, the neurological impairment caused by MS can directly affect the vestibular system, thereby boosting its market growth.

The World Health Organization (2021), stated that between 2015 to 2050, people falling between 60 years and above would be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years and above. This demographic shift is closely correlated with an increased prevalence of vestibular disorders, as the aging population is more susceptible to these conditions due to the physiological degeneration of the vestibular system and other senescent alterations in balance and spatial orientation.

Hence, all the above-mentioned factors are expected to drive the market for vestibular testing systems during the given forecast period from 2024 to 2030.

However, inaccuracies and unreliability of vestibular test results owing to several factors, such as errors in equipment calibration, and lack of skilled labor, among others are some factors that are expected to limit their end-user base, thus limiting the growth of the vestibular testing system market during the forecast period.

Vestibular Testing System Market Segment Analysis:

Vestibular Testing System Market by Product (Videonystagmography (VNG), Vestibular Evoked Myogenic Potentials (VEMP), Subjective Visual Vertical (SVV), and Rotary Chair Testing), Application (Diagnosis of Vestibular Disorders and Vestibular Rehabilitation), End-User (Hospital and Clinics, Ambulatory Surgical Centers, Audiology Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the vestibular testing system market, the VNG category is estimated to amass a significant revenue share in the vestibular testing system market in 2023. This can be attributed to the large patient population associated with vestibular disorders and the advantages specific to this category, which is expected to drive its market in the upcoming years.

Videonystagmography (VNG) offers numerous advantages over traditional vestibular testing systems, establishing it as a preferred diagnostic tool for vestibular and balance disorders. The utilization of high-resolution infrared cameras allows for a detailed analysis of nystagmus, a critical marker of vestibular pathology. VNG is non-invasive and provides greater patient comfort, as it does not necessitate skin or eye contact. The development of portable and wireless VNG systems further augments its applicability, enabling testing in diverse environments, including remote or home-based settings. This flexibility is particularly beneficial for patients with mobility challenges, thereby broadening the scope and accessibility of vestibular assessments.

The various technological developments in this category is estimated to push forward the market growth of vestibular testing systems. For instance, in July 2024 Interacoustics A/S stated the VisualEyes Videonystagmography (VNG) system combines videonystagmography, rotary chair testing, and the video head impulse test (vHIT) into one integrated system. This comprehensive diagnostic tool allows for a thorough assessment of the vestibular system, significantly enhancing the accuracy and efficiency of diagnosing balance and dizziness disorders.

Moreover, VNG systems integrate advanced software and algorithms, incorporating machine learning and artificial intelligence to facilitate automated data analysis and interpretation.

Therefore, owing to the various advantages and applications provided by VNG in vestibular disorder diagnosis, this category is expected to drive the overall growth of the vestibular testing system market during the forecast period.

North America Is Expected To Dominate The Overall Vestibular Testing System Market:

North America is expected to dominate the overall vestibular testing system market during the forecast period from 2024 to 2030. This is owing to several key factors. The region has a well-established healthcare infrastructure, which includes advanced medical facilities and widespread access to healthcare services. Additionally, North America has a high prevalence of vestibular disorders, which increases its demand for diagnostic and treatment solutions. The presence of leading medical device manufacturers and ongoing technological advancements in vestibular testing systems also contribute to market growth. Moreover, significant investment in healthcare research and development, coupled with favorable reimbursement policies, further supports the adoption of vestibular testing systems. Thus, all these factors combined are expected to drive the North American market for vestibular testing systems during the forecast period.

According to data from the National Institutes of Health (2023), 33 million adults in the United States were affected by vestibular disorders during 2018-2019. As per the same source, the National Health and Nutrition Examination Survey (NHANES) reported that 35% of U.S. adults aged 40 and above displayed signs of balance dysfunction. Also, it indicated that 3.5 million children and adolescents were affected by vestibular disorders, highlighting the widespread prevalence of these conditions across different age groups in the U.S. in 2018-2019. Thus, the significant prevalence of vestibular disorders among both adults and children underscores the critical need for accurate diagnosis and management. This widespread occurrence drives the demand for vestibular testing devices, promoting their growth as essential tools in the market.

According to the Anxiety & Depression Association of America (2022), it was reported that Generalized Anxiety Disorder affects 6.8 million adults. Panic disorder affects 6 million adults. Social Anxiety Disorder affects 15 million adults. While these disorders primarily affect one's psychological well-being, they can manifest physical symptoms that overlap with those of vestibular disorders. Vestibular disorders arise from dysfunction in the vestibular system, crucial for balance maintenance. Anxiety can heighten sensitivity to bodily sensations, leading to increased vigilance. As vestibular dysfunction underscores the need for thorough assessment and treatment, the demand for vestibular testing systems is rising.

Additionally, product developmental activities taking place in the region are also playing a major role in increasing the market for these testing systems. For instance, in April 2022, GyroStim became the first FDA-cleared device for treating balance disorders. This new balance treatment technology was potential to prevent falls and save the healthcare industry billions of dollars each year.

Thus, due to the interplay of all the above-mentioned factors, it will lead to an increase in the North American vestibular testing system market growth during the forecast period from 2024 to 2030.

Vestibular Testing System Market Key Players:

Some of the key market players operating in the vestibular testing system market include Interacoustics A/S, Natus Medical Incorporated, SECURE HEALTH, INC., Visteon Corporation, BioMed Jena GmbH, Esumedics GmbH, INVENTIS S.r.l., MedRx, Grason-Stadler (GSI), Happersberger otopront GmbH, Micro Medical Devices (MMD), Inc., Homoth Medizinelektronik GmbH & Co. KG, BeOn Solutions srl, Evolution Optiks Limited, and others.

Recent Developmental Activities In The Vestibular Testing System Market:

  • In June 2024, Evolution Optiks secured 510(k) clearance from the FDA for their new eye examination device, the LFR-260. This clearance was based on the results of a multi-centered, open-label, 2X2 crossover study involving 108 patients. The trial aimed to compare the performance of the LFR-260 neuro-optical testing device with videonystagmography (VNG) technology in assessing human vestibular disorders.
  • In September 2023, Evolution Optiks Limited, a privately held company specializing in light field technology, announced the start of a clinical study of its DeCon device for the evaluation of human vestibular disorders.

Key Takeaways From The Vestibular Testing System Market Report Study

  • Market size analysis for current Vestibular Testing System market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Vestibular Testing System market
  • Various opportunities available for other competitors in the Vestibular Testing System market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Vestibular Testing System market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Vestibular Testing System market growth in the coming future?

Target Audience Who Can Be Benefited From This Vestibular Testing System Market Report Study

  • Vestibular testing system product providers
  • Research organizations and consulting companies
  • Vestibular testing system related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in vestibular testing system
  • Various end-users who want to know more about the vestibular testing system market and the latest technological developments in the vestibular testing system market.

Frequently Asked Questions For The Vestibular Testing System Market:

1. What are vestibular testing systems?

Vestibular testing systems are medical devices and procedures used to evaluate the vestibular system, located in the inner ear and responsible for balance and spatial orientation. These tests are essential for diagnosing conditions that cause balance issues, dizziness, and vertigo, by assessing the function of the semi-circular canals, otolith organs, and associated nerves.

2. What is the market for vestibular testing system?

The vestibular testing system market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030.

3. What are the drivers for the vestibular testing system market?

The vestibular testing system market is slated to witness prosperity owing to the rising prevalence of vestibular disorders, such as vertigo, dizziness, and balance issues, increasing number of patients experiencing anxiety and psychological factors associated with vestibular disorders, among others are expected to drive the demand for comprehensive diagnostic solutions. The aging global population, which is more susceptible to balance-related disorders, also contributes to the growing market, as older adults are more likely to suffer from these conditions and seek medical intervention. Thus, all these factors serve as key factors driving the growth of the vestibular testing system market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the vestibular testing system market?

Some of the key market players operating in vestibular testing systems include Interacoustics A/S, Natus Medical Incorporated, SECURE HEALTH, INC., Visteon Corporation, BioMed Jena GmbH, Esumedics GmbH, INVENTIS S.r.l., MedRx, Grason-Stadler (GSI), Happersberger otopront GmbH, Micro Medical Devices (MMD), Inc., Homoth Medizinelektronik GmbH & Co. KG, BeOn Solutions srl, Evolution Optiks Limited, and others.

5. Which region has the highest share in the vestibular testing system market?

North America is expected to dominate the overall vestibular testing system market during the forecast period from 2024 to 2030. This is owing to several key factors. The region has a well-established healthcare infrastructure, which includes advanced medical facilities and widespread access to healthcare services. Additionally, North America has a high prevalence of vestibular disorders, which increases its demand for diagnostic and treatment solutions. The presence of leading medical device manufacturers and ongoing technological advancements in vestibular testing systems also contribute to market growth. Moreover, significant investment in healthcare research and development, coupled with favorable reimbursement policies, further supports the adoption of vestibular testing systems. Thus, all these factors combined are expected to drive the North America market for vestibular testing systems during the forecast period.

Table of Contents

1. Vestibular Testing System Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Vestibular Testing System Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Vestibular Testing System Market Key Factors Analysis

  • 5.1. Vestibular Testing System Market Drivers
    • 5.1.1. Rising prevalence of vestibular disorders
    • 5.1.2. Expansion of Healthcare Infrastructure
    • 5.1.3. Increasing number of patients associated with anxiety and psychological factors
    • 5.1.4. Rising geriatric population
  • 5.2. Vestibular Testing System Market Restraints and Challenges
    • 5.2.1. The unstable accuracy and unreliability of vestibular test results
    • 5.2.2. Lack of skilled labour and equipment calibration
  • 5.3. Vestibular Testing System Market Opportunities
    • 5.3.1. Integration of vestibular testing systems with electronic health records

6. Vestibular Testing System Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Vestibular Testing System Market Assessment

  • 7.1. By Product
    • 7.1.1. Videonystagmography (VNG)
    • 7.1.2. Vestibular Evoked Myogenic Potentials (VEMP)
    • 7.1.3. Subjective Visual Vertical (SVV)
    • 7.1.4. Rotary Chair Testing
  • 7.2. By Application
    • 7.2.1. Diagnosis of Vestibular Disorders
    • 7.2.2. Vestibular Rehabilitation
  • 7.3. By End-User
    • 7.3.1. Hospital and Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Audiology Centres
    • 7.3.4. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Vestibular Testing System Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Vestibular Testing System Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.3.3. India Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Vestibular Testing System Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Vestibular Testing System Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Vestibular Testing System Market Size in USD million (2021-2030)

8. Vestibular Testing System Market Company and Product Profiles

  • 8.1. Interacoustics A/S
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Natus Medical Incorporated
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. SECURE HEALTH, INC.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Visteon Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. BioMed Jena GmbH
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Esumedics GmbH
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. INVENTIS S.r.l.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. MedRx
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Grason-Stadler (GSI)
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Happersberger otopront GmbH
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Micro Medical Devices (MMD), Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Homoth Medizinelektronik GmbH & Co. KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BeOn Solutions srl
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Evolution Optiks Limited
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us